Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Suite 906 Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
30 June
Lunai Bioworks Inc. has filed 589 SEC EDGAR filings since 12 Aug 2011

SEC filing history

Showing 501-525 of 589 matching filings.

Per page
25
Current page
21
8-K File 000-54478

FORM 8-K

Filing date
27 Jun 2016
Reporting date
27 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54478

QUARTERLY REPORT

Filing date
13 May 2016
Reporting date
31 Mar 2016
Next action
Verify source filing
8-K File 000-54478

CURRENT REPORT

Filing date
05 Apr 2016
Reporting date
04 Apr 2016
Next action
Verify source filing
8-K File 000-54478

CURRENT REPORT

Filing date
10 Mar 2016
Reporting date
10 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54478

QUARTERLY REPORT

Filing date
12 Feb 2016
Reporting date
31 Dec 2015
Next action
Verify source filing
8-K File 000-54478

CURRENT REPORT

Filing date
08 Jan 2016
Reporting date
08 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-54478

DEFINITIVE PROXY STATEMENT

Filing date
01 Dec 2015
Reporting date
08 Jan 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54478

QUARTERLY REPORT

Filing date
13 Nov 2015
Reporting date
30 Sep 2015
Next action
Verify source filing
10-KT File 000-54478

TRANSITION REPORT

Filing date
28 Sep 2015
Reporting date
30 Jun 2015
Next action
Verify source filing
8-K File 000-54478

CURRENT REPORT

Filing date
01 Jul 2015
Reporting date
24 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
08 Jun 2015
Reporting date
30 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54478

QUARTERLY REPORT

Filing date
13 May 2015
Reporting date
31 Mar 2015
Next action
Verify source filing
8-K File 000-54478

FORM 8-K

Filing date
13 May 2015
Reporting date
10 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54478

FORM 8-K

Filing date
01 May 2015
Reporting date
28 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 000-54478

ANNUAL REPORT

Filing date
31 Mar 2015
Reporting date
31 Dec 2014
Next action
Verify source filing
8-K File 000-54478

CURRENT REPORT

Filing date
18 Mar 2015
Reporting date
12 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-86428

SC 13D

Filing date
05 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-86428

SC 13D

Filing date
05 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54478

CURRENT REPORT

Filing date
31 Dec 2014
Reporting date
31 Dec 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54478

CURRENT REPORT

Filing date
14 Nov 2014
Reporting date
13 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-54478

QUARTERLY REPORT

Filing date
13 Nov 2014
Reporting date
30 Sep 2014
Next action
Verify source filing
424B3 File 333-193965

PROSPECTUS SUPPLEMENT

Filing date
27 Oct 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54478

CURRENT REPORT

Filing date
27 Oct 2014
Reporting date
23 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-193965

424B3 filing

Filing date
15 Oct 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-54478

DANDRIT BIOTECH USA, INC. FORM 8-K

Filing date
15 Oct 2014
Reporting date
10 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .